Finasteride and Gynecomastia: Risk, Rates, and What to Do

Gynecomastia — enlargement or tenderness of breast tissue in men — is a recognized adverse effect of finasteride, occurring in approximately 0.4% of 1 mg users vs. 0.2% of placebo users in clinical trials. While uncommon, any breast lump or enlargement in a man warrants medical evaluation regardless of medication history, because breast cancer — though rare in men — is a clinical possibility that must be ruled out.

Why Finasteride Can Cause Gynecomastia

The proposed mechanism involves the androgen/estrogen balance in breast tissue:

1. Finasteride blocks DHT production, reducing the androgenic stimulus on breast tissue
2. Reduced DHT leads to a small compensatory increase in serum testosterone (typically 10–15%)
3. Some of this additional testosterone is converted (aromatized) to estradiol by the aromatase enzyme in peripheral tissues
4. The resulting shift in the testosterone:estradiol ratio — with relatively more estradiol and less DHT in breast tissue — can stimulate ductal and stromal proliferation, causing gynecomastia

Clinical Trial Rates

	Finasteride 1 mg	Placebo
Breast tenderness or enlargement	0.4%	0.2%

What to Do If You Notice Breast Changes

1. See a physician promptly. Any new breast lump, nipple discharge, or breast asymmetry in a man should be evaluated regardless of finasteride use — male breast cancer, while rare, requires clinical exclusion
2. Report to your prescribing physician. Gynecomastia should be documented; your physician may recommend stopping finasteride depending on severity
3. Laboratory evaluation. A physician may check estradiol, testosterone, TSH, and LH to assess the hormonal picture and rule out other causes of gynecomastia (hypogonadism, thyroid disease, liver disease, other medications)

Does Gynecomastia Resolve After Stopping Finasteride?

In most cases, breast tenderness resolves after stopping finasteride, as the androgen/estrogen balance normalizes. Established gynecomastia (with significant glandular tissue proliferation) may not fully regress; in rare cases, minor surgical correction is needed. Early-stage gynecomastia (primarily tenderness and early tissue growth) is more likely to resolve spontaneously or after stopping the drug.

See also: Full side effects hub | Finasteride side effects in men